Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

Epstein-Barr virus (EBV) is a human herpes virus that infects over 90% of the world’s population and is linked to development of cancer. In immune-competent individuals, EBV infection is mitigated by a highly efficient virus-specific memory T-cell response. Risk of EBV-driven cancers increases with...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Vaccines (Basel)
Главные авторы: Ahmed, Elshafa Hassan, Brooks, Eric, Sloan, Shelby, Schlotter, Sarah, Jeney, Frankie, Hale, Claire, Mao, Charlene, Zhang, Xiaoli, McLaughlin, Eric, Shindiapina, Polina, Shire, Salma, Das, Manjusri, Prouty, Alexander, Lozanski, Gerard, Mamuye, Admasu T., Abebe, Tamrat, Alinari, Lapo, Caligiuri, Michael A., Baiocchi, Robert A.
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2021
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8228306/
https://ncbi.nlm.nih.gov/pubmed/34073261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060555
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы